PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-154

  1. 1,316 Posts.
    lightbulb Created with Sketch. 263
    Please also remember that this is already an FDA approved drug. We are going for a repurposing, which makes the process easier, for sure.

    Additionally, the FDA recently approved the current/pending retired NFL players trial, which is certainly another brick in the wall.

    Results of this trial will give Para international exposure, as well as go a long way in getting Zilosul commercialised.

    DYOR...
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.